VIDA Diagnostics Inc., a medical software and services company based in the UI BioVentures Center and created through research at the UI College of Engineering, recently announced the company raised $5.1 million in Series B funding.

With an anticipated launch this summer of its signature invention—a device that allows patients with physical impairments to communicate with hospital staff—University of Iowa spinout company Voxello continues to draw significant investor interest while clinical trials are underway.